Results 21 to 30 of about 215,071 (215)

Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium

Hormone Research in Paediatrics, 2019
This update, written by authors designated by multiple pediatric endocrinology societies (see List of Participating Societies) from around the globe, concisely addresses topics related to changes in GnRHa usage in children and adolescents over the last ...
Kanthi Bangalore Krishna, J. Fuqua, A. Rogol, K. Klein, J. Popovic, C. Houk, E. Charmandari, Peter A. Lee   +7 more
semanticscholar   +1 more source

Cancer Therapy–Related Cardiac Dysfunction in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The risk of cardiac dysfunction for patients with prostate cancer undergoing androgen deprivation therapy (ADT) in the real‐world setting remains unclear.
Dong‐Yi Chen, Cheng‐Hung Lee, Ming‐Lung Tsai, Ming‐Jer Hsieh, Cheng‐Keng Chuang, See‐Tong Pang, Shao‐Wei Chen, Chi‐Nan Tseng, Shang‐Hung Chang, Pao‐Hsien Chu, I‐Chang Hsieh, Victor Chien‐Chia Wu, Wen‐Kuan Huang   +12 more
doaj   +1 more source

The Gonadotropin-Releasing Hormone Pulse Generator.

Endocrinology, 2018
The pulsatile release of GnRH and LH secretion is essential for fertility in all mammals. Pulses of LH occur approximately every hour in follicular-phase females and every 2 to 3 hours in luteal-phase females and males.
A. Herbison
semanticscholar   +1 more source

Gonadotropin releasing hormone agonists: Expanding vistas

Indian Journal of Endocrinology and Metabolism, 2011
Gonadotropin-releasing hormone (GnRH) agonists are derived from native GnRH by amino acid substitution which yields the agonist resistant to degradation and increases its half-life.
Navneet Magon
doaj   +1 more source

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

JCRPE, 2021
Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert, Amalie H. Hvelplund, Aase Handberg, Søren Hagstroem, Tina Lund Leunbach   +4 more
doaj   +1 more source

Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs

Frontiers in Oncology, 2019
Although significant progress has been made in the implementation of new breast cancer treatments over the last three decades, this neoplasm annually continues to show high worldwide rates of morbidity and mortality.
Maira Huerta-Reyes, G. Maya-Núñez, M. A. Pérez-Solis, E. López-Muñoz, N. Guillén, Jean-Christophe Olivo-Marin, Arturo Aguilar-Rojas   +6 more
semanticscholar   +1 more source

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System

Frontiers in Endocrinology, 2017
Gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone, and luteinizing hormone orchestrate the reproduction cycle and regulate the sex steroid secretion from the gonads.
Bodil Ohlsson, Bodil Ohlsson
doaj   +1 more source

The use of GnRH analogs in preserving ovarian function during chemotherapy

Middle East Fertility Society Journal, 2021
Background The literature has always been controversial on the use of gonadotropin-releasing hormone agonists in preserving fertility in women of childbearing age after chemotherapy; thereby, in this article, we will be discussing its use in preserving ...
Omar M. Odeh, Johnny Awwad, Dalia Khalife, Suleiman Ghunaim   +3 more
doaj   +1 more source

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis

Frontiers in Endocrinology, 2017
In several human malignant tumors of the urogenital tract, including cancers of the endometrium, ovary, urinary bladder, and prostate, it has been possible to identify expression of gonadotropin-releasing hormone (GnRH) and its receptor as part of an ...
C. Gründker, G. Emons
semanticscholar   +1 more source

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment

Clinical and Experimental Reproductive Medicine, 2016
Objective To determine the preferred regimen for women with adenomyosis undergoing in vitro fertilization (IVF), we compared the IVF outcomes of fresh embryo transfer (ET) cycles with or without gonadotropin-releasing hormone (GnRH) agonist pretreatment ...
C. Park, Min Hye Choi, K. Yang, I. Song
semanticscholar   +1 more source